Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/2003
06/05/2003US20030104570 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104478 Screening modulators of g-protein activity: for use in treatment of nervous system disorders
06/05/2003US20030104342 Use of ozone for the treatment of dental and oral conditions
06/05/2003US20030104053 Drug dispersed in a solid unitary matrix formed of poly(ethylene oxide) and hydroxypropyl methylcellulose.
06/05/2003US20030104050 Process for preparing quick dissolving, high loading ribavirin compositions
06/05/2003US20030103974 Administering an antibodies or enzyme inhibitor of prothrombinase; therapeutic treatment of bacterial and viral infections, allograft and xenograft rejection, cancer, glomerulonephritis, gastrointestinal disorders and fetal loss
06/05/2003US20030103969 Therapeutic treatment using an anti-CD14 antibody
06/05/2003US20030103954 Comprises vitamin D3 for regulating cell differentiation and/or cell proliferation
06/05/2003US20030103953 Comprises vitamin D3 for controlling cell differentiation and/or cell proliferation
06/05/2003US20030103912 Breaking, disrupting film in aqueous solution; preventioncoagulation
06/05/2003CA2468717A1 Aryl fused azapolycyclic compounds
06/05/2003CA2468705A1 Succinic acid salts of 5,8,14-triazatetracyclo'10.3.1.0<2,11>.0<4,9>-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
06/05/2003CA2468402A1 Ccr-3 receptor antagonists vii
06/05/2003CA2468184A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003CA2468159A1 4-aminoquinoline compounds
06/05/2003CA2468135A1 Ginger extract preparation
06/05/2003CA2468071A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003CA2468020A1 Osteopontin-related compositions and methods
06/05/2003CA2468015A1 2-aminoquinoline compounds
06/05/2003CA2467966A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
06/05/2003CA2467892A1 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003CA2467831A1 Mint extract and related pharmaceutical compositions
06/05/2003CA2467647A1 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma
06/05/2003CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003CA2466931A1 Antagonist anti-cd40 monoclonal antibody therapy for multiple sclerosis treatment
06/05/2003CA2466870A1 Methods for treating autoimmune disorders, and reagents related thereto
06/05/2003CA2466867A1 Treatment of hyperproliferative diseases using active vitamin d analogues
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/05/2003CA2435758A1 Polynucleotide therapy_against autoantigens for treating insulin dependent diabetes mellitus
06/04/2003EP1316547A1 Novel crystals of n-hydroxy-2(s)-methyl-5-ethoxymethoxy -4(s)- n-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient
06/04/2003EP1315837A2 5-hydroxytryptamine receptor gene polymorphisms and response to treatment
06/04/2003EP1315835A2 Directed differentiation of embryonic cells
06/04/2003EP1315812A2 Modified polypeptides stabilized in a desired conformation and methods for producing same
06/04/2003EP1315804A2 Novel mmp-2 derivatives for use as inhibitors of integrin alpha vbeta 3
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315758A2 Methods and reagents for protease inhibition
06/04/2003EP1315741A2 A method for treating allergies
06/04/2003EP1315736A2 Nucleoside derivatives for the treatment of hepatitis c
06/04/2003EP1315735A1 Phosphate derivatives as immunoregulatory agents
06/04/2003EP1315727A2 7-oxo pyridopyrimidines
06/04/2003EP1315726A1 7- oxo pyridopyrimidines as inhibitors of cellular proliferation
06/04/2003EP1315723A1 The hydrochloride salt of 5[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
06/04/2003EP1315718A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315717A1 Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315716A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315705A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315694A2 Inhibitors of alpha 4 mediated cell adhesion
06/04/2003EP1315505A2 Pharmaceutical compositions for headache, migraine, nausea and emesis
06/04/2003EP1315504A1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
06/04/2003EP1315499A1 Compositions and methods for the treatment of anorectal disorders
06/04/2003EP1315496A2 The treatment of inflammatory disorders
06/04/2003EP1315488A2 Pharmaceutical compositions containing aminothiazole derivatives for the treatment of colonic motor dysfunctions
06/04/2003EP1315485A1 Cathartic composition
06/04/2003EP1315481A1 Medicament for treating intestinal diseases
06/04/2003EP1315473A2 Use of ectoine or ectoine derivatives for oral care
06/04/2003EP1252150B1 Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
06/04/2003EP1196444B1 Extendin-4 conjugates and their medical use
06/04/2003EP1105390B1 Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases
06/04/2003EP1075476B1 Novel benzimidazoles and benzoxazoles
06/04/2003EP0977557B1 Pellet-type formulation intended for treating the intestinal tract
06/04/2003EP0964849B1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
06/04/2003EP0944616B1 Bicyclic aryl carboxamides and their therapeutic use
06/04/2003EP0927031B1 Pharmaceutical preparation containing nimesulide for oral administration
06/04/2003EP0775120B1 Novel pyrimidine derivatives and processes for the preparation thereof
06/04/2003EP0775118B1 Benzimidazole derivatives having dopaminergic activity
06/04/2003EP0773940B1 Process for synthesis of substituted sulphoxides
06/04/2003EP0679189B1 Cloning of enterokinase and method of use
06/04/2003EP0665752B1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
06/04/2003CN1422274A Alkylated imidazopyridine derivatives
06/04/2003CN1422273A 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases
06/04/2003CN1422272A Pyrrolopyridazine compound
06/04/2003CN1422271A Pyrrolopyrimidinone derivatives, process of preparation and use
06/04/2003CN1422270A Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
06/04/2003CN1422266A Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422230A Infusion packet with useful and decorative element, support member, delivery system and method
06/04/2003CN1422164A Preparations for preventing bile acid diarrhea
06/04/2003CN1422156A Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
06/04/2003CN1422155A Urease inhibitors
06/04/2003CN1422125A Composition comprising free amino acids
06/04/2003CN1422121A Protein stabilised emulsions
06/04/2003CN1421531A Prepn process of humanized monoclonal antibody resisting hepatitis B virus surface antigen
06/04/2003CN1421453A Structure and use of acanthus illicifolius glycoside B as one fatty alcohol glycoside compound
06/04/2003CN1421240A Chinese medicine prepn for treating throat diseases and stomatopathy and its prepn process
06/04/2003CN1421238A Natural bioreaction regulator with the functions of resisting cancer, resisting free radical damage and regulating immunity
06/04/2003CN1421234A Oral liquid for treating hepatitis B
06/04/2003CN1421229A Chinese medicine for treating hepatocirrhosis, hepatitis and liver cancer
06/04/2003CN1421221A Medicine for treating gastroduodenal ulcer
06/04/2003CN1421216A Sore ulcer treating medicine powder
06/04/2003CN1421212A Cell growth regulating factor J and its prepn process
06/04/2003CN1421204A Lafutidine injecta and its prepn
06/04/2003CN1110558C Novel growth/differentiation factor of the TGF-ÔÇÿbetaÔÇÖfamily
06/04/2003CN1110547C Strains of bacteria, pharmaceutical composition containing them, and use of the same strains in preventing and treating diseases
06/04/2003CN1110496C Tetrahydro Gamma-carbolines compound
06/04/2003CN1110490C Sulfamide-substituted condensed seven-membered ring compound, used as medicine and medical preparation containing the same
06/04/2003CN1110482C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
06/04/2003CN1110314C Chinese herb medicine for treating heptitis C
06/04/2003CN1110313C Medicine for preventing and curing cholesthiasis disease
06/04/2003CN1110303C Application of eight precious extract in preparing antiviral medicine
1 ... 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 ... 1258